NexEos Bio Announces Phase II Clinical Trial for Lead Diagnostic

NexEos Bio Announces Pipeline Expansion

NexEos Bio Names Dawn Rubel as President, Research and Development

Pivot Center: University of Utah researcher, Dr. Gerald Gleich of NexEos Bio recognized for decades-long career studying eosinophils

FDA Grants Orphan Drug Designation to NexEos Bio’s Investigational Radioimaging Agent as a Diagnostic for the Management of Eosinophilic Esophagitis

NexEos licenses novel University of Utah imaging tech for diagnosing eosinophil-related inflammation